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The lipocyte is an important source of laminin in the normal liver. We have investigated the expression of the 3 chains of laminin in isolated rat 
lipocytes. Both B, and B, chains, but not A, were found in medium from S-day-old lipocyte primary cultures by immunoblottingand immunopre- 
cipitation of 35S-labeled proteins after reducing SDS-polyacrylamide gel electrophorcsis. An additional polypeptide of M,=380 000 was identified 
by immunoprecipitation. Under non-reducing conditions only one M,=900 000 band was revealed. High levels of B, and Bz mRNAs were also 
demonstrated in S-day-old cultured lipocytes while at the time of seeding, only Bz chain mRNAs were clearly detectable. A chain mRNA was 
sonstantly absent. These results suggest hat lipocytes produce a variant form of laminin in primary culture and that the M,=380 000 polypeptide 
could be unrelated to the A chain of laminin. 
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1. INTRODLJCTION 
Laminin is the major noncollagenous glycoprotein of 
all basement membranes [1,2]. The most well studied 
laminin is from the mouse Engelbreth-Helm-Swarm 
(EHS) tumor [l] which was found to be composed of 
three genetically distinct chains, A (M,=400 000), B, 
CM,=210 000) and B2 (M,=%OO 000), which are held to- 
gether by disulfide bonds in a cross-shaped molecule [a]. 
When used as a substrate in vitro, EHS laminin may 
exert various biological activities including promoting 
a.dhesion, migration, growth, and differentiation of a 
variety of cells [3-51. Laminin of non-neoplastic origin 
may exhibit structural differences, including changes in 
the A, B, and B2 chain ratio and/or the presence of 
isoforms. Thus, many cells in culture and various tissues 
contain only small amounts of A chain, if any [6--g]. In 
addition, variants of laminin that contain polypeptides 
different from those found in the murine EHS molecule 
have been identified in several tissues, including pla- 
centa, heart and neuromuscular junctions [lo-l 51. 
In the liver, laminin is present mainly around vessels 
and bile ducts. It is also sparsely deposited in the space 
of Disse, at the contact sites of hepatocytes [ 161. In vitro, 
laminin is a potent regulator of the behaviour and func- 
tion of hepatocytes [17]. However, the relevance of these 
findings may depend on the actual structure of the mo- 
lecule in vivo. Indeed, hepatocytes may interact diffe- 
rently with the 3 chains of laminin [ 181, thereby resulting 
in the induction of specific regulatory signals. Since 
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lipocytes are both closely located to hepatocytes and 
one of the major sources of laminin in the liver /16,17], 
we have studied the expression of the 3 chains of these 
cells after their isolation. We show that hepatic lipocytes 
in culture express B, and Bz chains and a polypeptide 
of M,=380 000 which probably differs from the A chain 
of the EMS laminin. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Cell culture medium was from Ciibco. Collagenase and DNAse were 
purchased from Boehringer and pronase E from Merck. Nycodenz 
was obtained from Nyegaard and Co. (Oslo, Norway). Anti-laminin 
antibodies were obtained following injection of laminin purified from 
the EHS tumor in a New Zealand rabbit (Levavasseur et al., unpub- 
lished). Anti-desmin antibodies were from Dako. L-fsS]methionine 
(specific activity 1475 Ci/mmol) was obtained from Amersham. 
2.2. cDNA probes 
Laminin A chain cDNA probe was a 1.2 kb EcoRI fragment of 
IA-E3 cloned from an ENS tumor cell cDNA library [19]. Laminin 
B, chain cDNA probe was a 05 kb EcoRI-Hind111 fragment of P24 
cloned from mouse differentiated F9 cell cDNA library [20]. Laminin 
Bz chain cDNA probe was a 1.5 kb EcoRI-HindHI fragment of P7 
cloned from an F9 cell cDNA library [21]. The parietal yolk cell line 
(PYS, a gift from Dr P. Burbelo, NIDR, Bethesda) was used as a 
positive control for Northern blot hybridization with the laminin A 
chain cDMA probe. 
2.3. Cell cdlure 
Ito cells were obtained from G-month- to l-year-old Sprague-Daw- 
ley male rats. Non parenchymal iver cells were first isolated using the 
nronase,-collagenase method [22,23] with slight modifications. Ito cells 
ivere purified using a single-step density gradient centrifugation with 
Nycodcnz at final concentration of 11.4%. Cells were plated in Dul- 
Jecco minimal essential medium containing 10% fetal calf serum 
:FCS). Culture medium was renewed daily. Purity of the Ito cell 
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Fig, 1. (A) Phase contrast microscopic observation of S-day-old hepatic lipocytes culture. (B) lmmunofluorescent staining of desmin in the same 
field (x 240). 
cultures was assessed on the basis of typical phase-contrast micro- 
scopic appearance, vitamin A-specific autofluorescence [23,24], red oil 
staining [25] positivity for desmin [23,26] and lack of endogenous 
pcroxidase activity and factor VIII. All experiments were performed 
5 days after cell seeding, except for Northern blot analyses which were 
performed with both freshly isolated cells and S-day cultured lipocy- 
tes. 
2.4. Fixation and itntnunocytochettristr~ 
sium chloride method [27]. RNAs (IO pg per lane) were resolved by 
electrophoresis on a 1% agarose slab gel with 10 mM sodium phos- 
phate pH 7.4 containing I. I M formaldehyde and transferred onto 
nitroccllulose sheets. Filters were hybridized in 3xSSC. 0.2% polyvi- 
nylpyrrolidone, 0.2% Ficoll. 0.1% SDS, 0.1% BSA and 10% dextran 
sulfate, The filters were washed for 30 min with 3xSSC at 6S°C, and 
then with IxSSC, 0.1% SDS for 30 min at 65°C. 
Cell cultures were rapidly washed with phosphate buffered saline 3. RESULTS 
(PBS) pH 7.5, and then fixed with a 4% paraformaldehyde solution 
buffered with 0.1 M cacodylate, pH 7.4, for 45 min at 4OC. Subse- Laminin production was studied in Sday-old cul- 
quently, desmin and factor VIII were localized using indirect immuno- tured hepatic lipocytes. At that time the cells were well 
fluorescence and immunoperoxidase techniques, respectively. spread and they still exhibited typical morphological 
2.5. Imtttunoprecipitnrion appearance with refringent globules and spindle-like ex- 
Cell cultures were incubated with 40 pCi [“‘S]menthionine per ml of tensions under phase-contrast microscopy (Fig. IA). 
methionine-free medium containing 10% FCS. After I2 h, the medium Over 95% of the cells were positive for both desmin 
was removed and supplemented with I mM phenylmethylsulfonyl. 
The medium was centrifuged and then incubated for 4 h with anti- 
(Fig. 1B) and vitamin A autofluorescence (data not 
laminin antibodies prior to addition of protein A-Sepharose, which 
shown). Endogenous peroxidase activity was u’ndetect- 
has been first soaked with non-labeled medium for I h. Then, beads able while no cell was found to stain for factor VIII 
were washed twice with PBS, followed by Ripa buffer containing IO antibodies (data not shown). 
mM Tris-HCI, pH 7.2, 0.13 M NaCI, 5 mM MgCl*. 2 mM EDTA, 
0.01% sodium dodecyl sulfate (SDS) and 10 mM Tris-HCI, pH 7.4. 
Specificity of laminin antibodies was assessed by im- 
Subsequently, the beads were mixed with sample buffer containing 
munoblotting against the purified basement membrane 
10% SDS with or without 5% /3-mercaptoethanol, and then loaded on 
components laminin and collagen IV. Only 2 bands 
a 5% SDS-polyacrylamide gel. Culture media incubated with non- 
immune serum were used as controls. 
0 2 3 kBa 4 5 kDe 
2,6. Ittv~umoblo~~ing 
Proteins were precipitated from the medium with 10% trichloroacet- 
ic acid. Pellets were washed twice with acetone, dried and then mixed 
with sample buffer containing or not S%P-mercaptoethanol. Proteins 
were resolved on a 5% SDS-polyacrylamide gel and transferred onto 
nitrocellulose sheets. Then filters were incubated for 2 h with Tris- 
buffered saline (0.05 M Tris-HCI, pH 7,4, 0.15 M NaCI) containing 
1.5% BSA and 1.5% dried milk. Then the sheets were incubated for 
I h with anti-laminin antibodies dilu::? (l/250) in the same buffer 
containing 0,25 M NaCl and 0.3% Nonidet. Filters were washed twice 
and then incubated with horseradish peroxidase-labeled anti-rabbit 
antibodies. Rcvclation was performed using a 5% chloronaphtol solu- 
tion. Laminin purified from EHS sarcoma was used as standard. 
Fig. 2, Immunoblotting of laminin. Media from 5.day-old hepatic 
lipocyle cultures (Iancs I and 4), and laminin (lanes 2 and 5) collagen 
IV (lane 3) extracted from the EHS tumor were resolved by 5% SDS- 
2.7. trtkNA cttrcttpsis 
Total RNAs wcrc isolated using the gu;%r.idinium-thiocyanatc/cc- 
polyacrylanride gel clcctrophoresis with (lancs I, 2 and 3) or without 
(lanes 4 and 5) 5% &mcrcaptoethanol. Arrow, laminin B chains. 
Standard molecular weights, x IOXf. 
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Fig. 3. Immunoprecipitation of “‘S-labellecl aminin resolved by 5% 
SDS-polyacrylamide gel electrophoeesis with (lanes 1 and 2) or with- 
out (lanes 3 and 4) 5%@nercaptoethanol. Lanes I and 3. media from 
5.day-old hepatic lipocyte cultures; lanes 2 and 4, non-immune serum. 
Double arrow, M, 380 000 polypeptide. Standard molecular weights, 
x lO”3. 
whose sizes correspond to the A chain (upper band) and 
the B, and Bz. chains (lower band) were visualised with 
purified larninin while anti-laminin antibodies did not 
react with collagen IV (Fig. 2, lanes 2 and 3). 
The presence of laminin in media from 5-day-old cul- 
tures was assessed by immunoblotting. After reducing 
SDS-electrophoresis and transfer to nitrocellulose fil- 
ters, incubation of sheets with anti-laminin antibodies 
revealed the presence of a band co-migrating with the 
I3 chains of EHS laminin (Fig. 2, lane 1). Under non- 
reducing conditions, only one M,=900 000 band co-mi- 
grating with non-reduced purified laminin was evident 
(Fig. 2, lane 4). 
Eaminin synthesis was studied in these cultures by 
immunoprecipitation of the 35S-labeled proteins (Fig. 
3). Under reducing conditions, media of cultured lipo- 
cytes contained 2 radiolabeled polypeptides of 
M,=200 000 and 220 000 respectively, comigrating with 
A 1 
Fig. 4. Northern blot analysis oflaminin A (A), 13, (B,) and Bz chain 
(B,) mKNA in freshly isolated lipocytes (lane I) and S-day-old cultu- 
red hepatic lipocytcs (lane 2). The filter, hybridized with the A cDNA 
probe, was exposed far IO days, PYS, parietal yolk sac rat tumor. 
Our data suggest that cultured lipocytes express a 
variant form of laminin composed of B,, B, and an 
M,=380 000 polypeptide not related to the A chain. 
Indeed, neither A chain nor A chain mRNA were visua- 
lized by immunoblotting and Northern blotting, respec- 
tively. However, an M,=380 000 polypeptide was found 
to be immunoprecipitated with anti-laminin antibodies. 
Since only an M,=900 000 polypeptide was visualized 
under non-reducing conditions, the Mr=380 000 poly- 
peptide probably formed a complex with B, and B2 
chains by disulfide bonds. Our results contradict the 
conclusions from Maher et al., that hepatic Iipocytes 
synthetize an intact from of laminin in culture [28]. 
However, neither immunoblotting nor Northern blot- 
ting were performed in this study. Further works are 
needed to investigate whether the M,=380 000 polypep- 
tide corresponds to a polypeptide not related to the A 
chain of the EI-IS laminin, e.g. merosin, or a polypeptide 
generated by alternative splicing of the A chain tran- 
script. It is noteworthy that homologues of laminin 
chains have been found in several tissues including pla- 
centa [l4], neuromuscular junction [13], and heart [12]. 
In addition, cells in culture such as adipocytes [1 1 J endo- 
thelial cells [ 151 and hepatoma cells [30] may contain an 
A-like molecule not related to the A chain of EHS lami- 
nin. 
We have previously shown by immunoelectron mi- 
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the B chains of purified laminin. In addition, an 
M,=380 000 band had migration distance close to that 
of the A chain of EHS laminin. This polypeptide was 
often resolved as a doublet (Fig. 3, lane 1). An addi- 
tional radiolabeled band which probably corresponds 
to entactin had an estimated size of M,=l60 000. Under 
non reducing conditions, only one M,=900 000 radio- 
labeled band comigrating with the El-IS laminin was 
revealed from the immunoprecipitated 3SS-medium 
(Fig, 3, lane 3). 
The steady-state levels of laminin A, B, and Bz chain 
mRNAs from both freshly isolated and 5-day-old cultu- 
red hepatic lipocytes were studied by Northern blot 
hybridization. only laminin B2 chain mRNA was 
clearly detectable in freshly isolated lipocytes (Fig. 4). 
After 5 days, cultured lipocytes contained abundant la- 
minin B, and Br chain mRNAs while A chain mRNA 
was constantly undetectable, even after a 10 day film 
exposure (Fig. 4). 
4. DISCUSSION 
Using both immunoblotting and immunoprecipita- 
lion of released radiolabeled proteins, we clearly show 
that lipocytes synthetize and secrete high levels of lami- 
nin I3 chains in culture. Their production was supported 
by the presence of B, and Bz chain mRNAs. These 
results confirm and extend previous finding suggesting 
that lipocytes are one of the major cellular sources of 
laminin in the liver [16,28,29]. 
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cr~scopy that lipocytes are laminin producers in both 
normal and fibrotic livers 1161. Only IS, chain mRNAs 
were clearly detectable in freshly isolated lipocytes by 
Northern blotting, thus suggesting that laminin genes 
are not coordinately expressed by these cells in vivo. Pt 
cannot be excluded, however, that these genes are tran- 
scribed at low level and/or mRNAs are rapidly proces- 
sed and degraded uring cell isolation. This observation 
does not support those from Milani et al. /31] showing 
the presence of 14, chain gene transcripts in sinusoidal 
cells by in situ hybridization on liver slices. Since endo- 
thelial cells also produce laminin in the liver [16,29], and 
since it is difficult o distinguish the endothelial cells and 
lipocytes under light microscopy, further study using 
purified endothelial cells from liver is required to clarify 
this point. 
Lower amounts of Bt chain rnRNA were found in 
freshly isolated cells when compared with 5-day-old li- 
pocyte cultures, while B, chain mRNA was clearly de- 
tectable in culture only. It has been shown that hepatic 
lipocytes undergo changes in morphology and gene ex- 
pression when cultured in vitro. For example they ex- 
press more collagens and proteoglycans after several 
days than in short-term primary culture 124,323. Similar 
observations have been made with hepatocyte primary 
cultures. These cells, which do not synthesize significant 
amounts of collagens and laminin in the normal liver, 
start producing the B, and Bz chains after a few hours 
in culture [33]. 
In summary, our data indicate that lipocytes express 
a variant from of laminin which lacks the A chain. 
Further work is required to characterize the 
&I,=380 00 chain that is synthesized by lipocytes in 
culture. These data should provide new insights into the 
actual form of laminin in the liver and, consequently, 
its effects on hepatocyte behavior. 
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